Teleflex Incorporated (NYSE:TFX) Stock Holdings Lifted by Brown Advisory Inc.

Brown Advisory Inc. lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 34.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,524 shares of the medical technology company’s stock after buying an additional 643 shares during the quarter. Brown Advisory Inc.’s holdings in Teleflex were worth $349,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Headlands Technologies LLC bought a new stake in Teleflex in the 4th quarter valued at about $29,000. MassMutual Private Wealth & Trust FSB increased its stake in Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock valued at $27,000 after buying an additional 100 shares during the period. Whipplewood Advisors LLC increased its stake in Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock valued at $32,000 after buying an additional 231 shares during the period. True Wealth Design LLC increased its stake in Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock valued at $48,000 after buying an additional 104 shares during the period. Finally, State of Wyoming acquired a new position in Teleflex during the 4th quarter valued at about $62,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Performance

TFX stock opened at $113.50 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. The stock has a market cap of $5.02 billion, a P/E ratio of 35.80, a P/E/G ratio of 1.81 and a beta of 1.08. The firm has a 50 day simple moving average of $121.42 and a 200 day simple moving average of $142.61. Teleflex Incorporated has a 52 week low of $113.32 and a 52 week high of $249.91.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to analysts’ expectations of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The firm’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same period last year, the company posted $3.21 earnings per share. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date was Tuesday, May 20th. Teleflex’s dividend payout ratio (DPR) is presently 42.90%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on TFX. Royal Bank Of Canada lowered their price objective on shares of Teleflex from $145.00 to $130.00 and set a “sector perform” rating on the stock in a research note on Tuesday. Morgan Stanley lowered their price objective on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Monday, May 5th. Mizuho set a $155.00 price objective on shares of Teleflex in a research note on Wednesday, April 16th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. Finally, Wells Fargo & Company decreased their target price on shares of Teleflex from $146.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, May 2nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Teleflex currently has a consensus rating of “Hold” and a consensus price target of $162.75.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.